Evidences for the existence of a low dopaminergic tone in polycystic ovarian syndrome: Implications for OHSS development and treatment

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 8, 2011, Pages 2484-2492

  Gómez, Raúl ^a   Ferrero, Hortensia ^a   Delgado Rosas, Francisco ^b   Gaytan, Maria ^b   Morales, Concepción ^c   Zimmermann, Ralf C ^d   Simón, Carlos ^a   Gaytan, Francisco ^c   Pellicer, Antonio ^a  

^a Instituto Universitario IVI INCLIVA   (Spain)

^b Fundación IVI Madrid   (Spain)

^c UNIVERSITY OF CÓRDOBA   (Spain)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE; CHORIONIC GONADOTROPIN; DOPAMINE; DOPAMINE 2 RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC ACTIVITY; FEMALE; GRANULOSA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LUTEAL CELL; OOCYTE; OVARY FOLLICLE; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; THECA CELL; VASCULARIZATION;

ADULT; CELLS, CULTURED; DOPAMINE; DOPAMINE AGONISTS; ERGOLINES; FEMALE; GRANULOSA CELLS; HUMANS; LUTEAL CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; OOCYTES; OVARIAN HYPERSTIMULATION SYNDROME; POLYCYSTIC OVARY SYNDROME; RECEPTORS, DOPAMINE D2; RISK FACTORS; SIGNAL TRANSDUCTION; TISSUE BANKS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; YOUNG ADULT;

EID: 79961226226     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-0075     Document Type: Article

References (22)

1. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19-25
2. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).Hum Reprod 19:41-47
3. Kamat BR, Brown LF, Manseau EJ, Senger DR, Dvorak HF 1995 Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am J Pathol 146:157-65
4. Agrawal R, Jacobs H, Payne N, Conway G 2002 Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries. Fertil Steril 78:1164-1169 (Pubitemid 35463108)
5. Geva E, Jaffe RB 2000 Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 74:429-438
6. Delgado-Rosas F, Gaytán M, Morales C, Gómez R, Gaytán F 2009 Superficial ovarian cortex vascularization is inversely related to the follicle reserve in normal cycling ovaries and is increased in polycystic ovary syndrome. Hum Reprod 24:1142-1151
7. Peitsidis P, Agrawal R 2010 Role of vascular endothelial growth factor in women with PCO and PCOS: a systematic review. Reprod Biomed Online 20:444-452
8. Neulen J, Yan Z, Raczek S, Weindel K, Keck C, Weich HA, Marmé D, Breckwoldt M 1995 Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 80:1967-1971
9. Cristina C, Díaz-Torga G, Baldi A, Góngora A, Rubinstein M, Low MJ, Becú-Villalobos D 2005 Increased pituitary vascular endothelial growth factor-A in dopaminergic D2 receptor knockout female mice. Endocrinology 146:2952-2962 (Pubitemid 41002802)
10. Gómez R, Gonzalez-Izquierdo M, Zimmermann RC, Novella-Maestre E, Alonso-Muriel I, Sanchez-Criado J, Remohi J, Simon C, Pellicer A 2006 Low dose dopamine agonist administration blocks VEGF mediated vascular permeability without altering VEGFR-2 dependent luteal angiogenesis in a rat ovarian hyperstimulation model. Endocrinology 147:5400-5411 (Pubitemid 44790595)
11. Alvarez C, Martí-Bonmatí L, Novella-Maestre E, Sanz R, Gómez R, Fernández-Sánchez M, Simón C, Pellicer A 2007 Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction. J Clin Endocrinol Metab 92:2931-2937 (Pubitemid 47236352)
12. Youssef MA, van Wely M, Hassan MA, Al-Inany HG, Mochtar M, Khattab S, van der Veen F 2010 Can dopamine agonists reduce the incidence and severity of OHSS in IVF/ICSI treatment cycles? A systematic review and meta-analysis. Hum Reprod Update 16:459-466
13. Rey-Ares V, Lazarov N, Berg D, Berg U, Kunz L, Mayerhofer A 2007 Dopamine receptor repertoire of human granulosa cells. Reprod Biol Endocrinol 5:40
14. Ferrero H, Gaytan F, Delgado-Rosas F, Gaytan M, Gomez R, Simon C, Pellicer A 2010 O-148 Dopamine receptor 2 (drd2) activation inhibits VEGF secretion in granulosa luteinized cells: implications for OHSS treatment in low drd2 milieus. Hum Reprod 25(Suppl 1):i56-i58
15. Hernández I, Parra A, Méndez I, Cabrera V, Cravioto MC, Mercado M, Díaz-Sánchez V, Larrea F 2000 Hypothalamic dopaminergic tone and prolactin bioactivity in women with polycystic ovary syndrome. Arch Med Res 31:216-222 (Pubitemid 30392362)
16. Garrido N, Albert C, Krüssel JS, O'Connor JE, Remohí J, Simón C, Pellicer A 2001 Expression, production, and secretion of vascular endothelial growth factor and interleukin-6 by granulosa cells is comparable in women with and without endometriosis. Fertil Steril 76:568-575
17. Rougé-Pont F, Abrous DN, Le Moal M, Piazza PV 1999 Release of endogenous dopamine in cultured mesencephalic neurons: influence of dopaminergic agonists and glucocorticoid antagonists. Eur J Neurosci 11:2343-2350 (Pubitemid 29292328)
18. Basu S, Nagy JA, Pal S, Vasile E, Eckelhoefer IA, Bliss VS, Manseau EJ, Dasgupta PS, Dvorak HF, Mukhopadhyay D 2001 The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med 7:569-574 (Pubitemid 32448324)
19. Stanek MB, Borman SM, Molskness TA, Larson JM, Stouffer RL, Patton PE 2007 Insulin and insulin-like growth factor stimulation of vascular endothelial growth factor production by luteinized granulosa cells: comparison between polycystic ovarian syndrome (PCOS) and non-PCOS women. J Clin Endocrinol Metab 92:2726-2733 (Pubitemid 47037382)
20. Wang TH, Horng SG, Chang CL, Wu HM, Tsai YJ, Wang HS, Soong YK 2002 Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor. J Clin Endocrinol Metab 87:3300-3308
21. Mayerhofer A, Smith GD, Danilchik M, Levine JE, Wolf DP, Dissen GA, Ojeda SR 1998 Oocytes are a source of catecholamines in the primate ovary: evidence for a cell-cell regulatory loop. Proc Natl Acad Sci USA 95:10990-10995 (Pubitemid 28413181)
22. Greiner M, Paredes A, Rey-Ares V, Saller S, Mayerhofer A, Lara HE 2008 Catecholamine uptake, storage, and regulated release by ovarian granulosa cells. Endocrinology 149:4988-4996